Candidacy for sorafenib in HCC patients: is there a slippery slope beyond a SHARP edge?
- PMID: 21548474
Candidacy for sorafenib in HCC patients: is there a slippery slope beyond a SHARP edge?
Comment on
-
What is the indication for sorafenib in hepatocellular carcinoma? A clinical challenge.Oncology (Williston Park). 2011 Mar;25(3):283-91, 295. Oncology (Williston Park). 2011. PMID: 21548473 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical